Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122050555 | 12205055 | 5 | F | 20140923 | 20160823 | 20160323 | 20160829 | EXP | PHHY2016DE037020 | NOVARTIS | 0.00 | E | F | Y | 94.00000 | KG | 20160829 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122050555 | 12205055 | 1 | PS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, QMO (EVERY 4 WEEKS) | 21223 | 4 | MG | SOLUTION FOR INJECTION | /month | ||||||
| 122050555 | 12205055 | 2 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, QMO (EVERY 3 MONTHS) | 21223 | 4 | MG | SOLUTION FOR INJECTION | /month | ||||||
| 122050555 | 12205055 | 3 | C | LETROZOLE. | LETROZOLE | 1 | Unknown | Y | 0 | ||||||||||
| 122050555 | 12205055 | 4 | C | ANASTROZOLE. | ANASTROZOLE | 1 | Unknown | Y | 0 | ||||||||||
| 122050555 | 12205055 | 5 | C | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | Y | 0 | 5 | MG | QD | ||||||
| 122050555 | 12205055 | 6 | C | EXEMESTANE. | EXEMESTANE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122050555 | 12205055 | 1 | Metastases to bone |
| 122050555 | 12205055 | 2 | Breast cancer metastatic |
| 122050555 | 12205055 | 3 | Product used for unknown indication |
| 122050555 | 12205055 | 4 | Product used for unknown indication |
| 122050555 | 12205055 | 5 | Breast cancer metastatic |
| 122050555 | 12205055 | 6 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122050555 | 12205055 | OT |
| 122050555 | 12205055 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122050555 | 12205055 | Breast cancer | |
| 122050555 | 12205055 | Feeding disorder | |
| 122050555 | 12205055 | Inappropriate schedule of drug administration | |
| 122050555 | 12205055 | Lymph node pain | |
| 122050555 | 12205055 | Lymphadenopathy | |
| 122050555 | 12205055 | Malignant neoplasm progression | |
| 122050555 | 12205055 | Metastases to bone | |
| 122050555 | 12205055 | Metastases to lung | |
| 122050555 | 12205055 | Metastases to lymph nodes | |
| 122050555 | 12205055 | Osteonecrosis of jaw | |
| 122050555 | 12205055 | Pain | |
| 122050555 | 12205055 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122050555 | 12205055 | 1 | 20101220 | 0 | ||
| 122050555 | 12205055 | 2 | 20160418 | 0 | ||
| 122050555 | 12205055 | 3 | 20101115 | 20141020 | 0 | |
| 122050555 | 12205055 | 4 | 20101115 | 20141020 | 0 | |
| 122050555 | 12205055 | 5 | 20141117 | 20150222 | 0 | |
| 122050555 | 12205055 | 6 | 20141117 | 0 |